Richard A. Messmann

4.7k citations
49 papers · 3.2k indexed · 1 hit paper · h-index 21
Topics
Radiopharmaceutical Chemistry and Applications (11 papers)Prostate Cancer Treatment and Research (10 papers)Acute Lymphoblastic Leukemia research (9 papers)

In The Last Decade

Richard A. Messmann

48 papers receiving 3.2k citations

Hit Papers

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant...202120262022202420214008001.2k

Peers

Richard A. Messmann
Comparison fields: 5 of 109
  • Pulmonary and Respiratory Medicine 1.4k
  • Radiology, Nuclear Medicine and Imaging 1.3k
  • Oncology 1.2k
  • Molecular Biology 976
  • Cancer Research 362
Replace Wouter B. Nagengast with:
Wouter B. Nagengast Netherlands
Valentina Boni Spain
Scott N. Holden United States
Marjolijn N. Lub–de Hooge Netherlands
Muralidhar Beeram United States
Stephen D. Rubin United States
Neville Davidson United Kingdom
Komal Jhaveri United States
Paula M. Fracasso United States
Paul Frankel United States
Richard A. Messmann relative to Wouter B. Nagengast Netherlands Wouter B. Nagengast's profile →
Citations per field
00.5×1.5×1.8×
Wouter B. Nagengast · 1×
Citations per year

Countries citing papers authored by Richard A. Messmann

Since Specialization
Citations

This map shows the geographic impact of Richard A. Messmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard A. Messmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard A. Messmann more than expected).

Fields of papers citing papers by Richard A. Messmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard A. Messmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard A. Messmann. The network helps show where Richard A. Messmann may publish in the future.

Co-authorship network of co-authors of Richard A. Messmann

This figure shows the co-authorship network connecting the top 25 collaborators of Richard A. Messmann. A scholar is included among the top collaborators of Richard A. Messmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard A. Messmann. Richard A. Messmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 3
3 3
4 76
5
Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic
1
6 5
7 62
8 115
9 169
10 70
11 3
12 33
13 41
14
Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical Folatescan.
63
15 127
16 14
17 18
18 20
19 19
20
The toxicity of deglycosylated ricin A chain-containing immunotoxins in patients with non-Hodgkin's lymphoma is exacerbated by prior radiotherapy: a retrospective analysis of patients in five clinical trials.
39

About Richard A. Messmann

Richard A. Messmann is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 49 papers that have together received 3.2k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (11 papers), Prostate Cancer Treatment and Research (10 papers) and Acute Lymphoblastic Leukemia research (9 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.3k citations), Oncology (1.2k citations) and Pulmonary and Respiratory Medicine (1.4k citations). Richard A. Messmann has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Oliver Sartor, Michael J. Morris, Bernd J. Krause, Michelle DeSilvio, Karim Fizazi, Kim N., Johann S. de Bono, Kambiz Rahbar, Scott T. Tagawa and Tomasz M. Beer. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026